Abstract:
The present invention relates to a novel genipin derivative represented by formula (I), which has anti hepatitis B virus (HBV) activity, in which R1 represents lower alkyl, benzyl, etc., R2 represents hydroxymethyl, formyl, acetyl, etc., R3 represents methoxycarbonyl, formyl, etc., its pharmaceutically acceptable salt, and stereoisomer.